Harrison Reed Long, PA

Harrison Long practices at Pure Psychiatry of Michigan in Wayne, Michigan.

Harrison Long's NPI, 1578175410, was assigned on August 21, 2020. Harrison Long holds Michigan license 5601010132.

Harrison Long's primary practice is Pure Psychiatry of Michigan, at 34841 Veterans Plz, Wayne, MI 48184 in Wayne County. The practice phone is (313) 292-7640.

Harrison Long's primary practice is Pure Psychiatry of Michigan in Wayne, Michigan. The medical group on file is Pure Psychiatry. Dmand AI also links Harrison Long to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Harrison Long practices. Vendor and product names are available with a free account.

Psychiatry is Harrison Long's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Harrison Long is licensed in Michigan.

CMS data shows 242 Medicare services from Harrison Long across 1 procedure code in 2024, all of them office visits, for 37 Medicare patients. Medicare paid $17,646 for them. Every service was in an office.

CMS counts 37 Medicare patients who saw Harrison Long in 2024. The largest group is 65 to 74, with 16 patients. 75% of them have anxiety, and 75% have mood disorders. 54% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Harrison Long's median patient age at 37, with 60% women.

In 2024, Harrison Long wrote 2,141 Medicare Part D claims for 114 patients. 90% of them were for generic drugs. CMS names the drug for 2,044 of them, across 47 drugs with 11 or more claims each, at $249,133 in total drug cost. In 2023, CMS named 1,715 claims across 40 drugs.

Harrison Long accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Harrison Long as offering telehealth.

CMS Open Payments shows 332 general payments to Harrison Long from 29 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 99% of the total. ITI, Inc. paid the most, $1,325.